Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
CardConnect® and FinTech Acquisition Corp. Announce Merger Agreement Combining Businesses
-
Energy Fuels to Increase Lower-Cost ISR Uranium Production Profile through Acquisition of Mesteña Uranium
-
Generation Success Power Series - Showcasing the UK's Asian Business Leaders
-
Cantor Fitzgerald Downgrades Garrison Capital (GARS) to Hold
-
Cantor Fitzgerald Downgrades Bonanza Creek Energy (BCEI) to Hold
-
Fitch Affirms Cantor Fitzgerald at 'BBB-'; Outlook Stable
-
Fitch Affirms BGC at 'BBB-'; Upgrades GFI to 'BBB-'; Outlook Stable
-
Freddie Mac Enhances Disclosures and Announces Intent to Sell $475 Million in Second STACR Offering This Year
-
EastBay Asset Management Urges Shutterfly (SFLY) to Conduct Formal Strategic Review
-
Tetragon Financial Group Limited - 2015 Annual Report (Period ended 31 Dec 2015)
-
Irish instability looms as rival parties doubt coalition prospects
-
With U.S. market volatility down, protection gets cheap
-
Notable Analyst Rating Changes 2/26: (ACHN) (NFX) (STAG) Upgraded; (BBY) (VIPS) (GG) Downgraded
-
Cantor Fitzgerald Starts Smith & Nephew (SNN) at Hold
-
Cantor Fitzgerald Starts Shire (SHPG) at Buy
-
Cantor Fitzgerald Starts GlaxoSmithKline (GSK) at Hold
-
Form 4 BGC Partners, Inc. For: Feb 23 Filed by: CANTOR FITZGERALD, L. P.
-
Orchid Island Capital Announces Fourth Quarter 2015 Results
-
CGI to present at the Cantor Fitzgerald 3rd Annual Internet & Technology Conference on February 25 in New York City
-
Cantor Fitzgerald Downgrades Advisory Board Company (ABCO) to Hold
-
Shutterstock to Present at Upcoming Investor Conferences
-
Founding Vonage CTO Louis Holder Joins YipTV Executive Team
-
Wix.com to Present at Upcoming Investor Conferences
-
Etsy to Present at the Cantor Fitzgerald 3rd Annual Internet & Technology Conference
-
DHI Group, Inc. to Present at the Cantor Fitzgerald Internet and Technology Conference
-
Cimpress to Present at the Cantor Fitzgerald Internet and Technology Conference
-
Quotient to Present at Cantor Fitzgerald 3rd Annual Internet & Technology Conference
-
Banks build ETF businesses as growth stalls in bond trading
-
Ur-Energy Announces Completion Of Bought Deal Financing
-
Cantor Fitzgerald Downgrades Tonix Pharma (TNXP) to Spec. Buy
-
Ampio Clarifies ATM Program
-
Direct reservations help TripAdvisor book profit beat
-
Orchid Island Capital Announces February 2016 Monthly Dividend and January 29, 2016 RMBS Portfolio Characteristics
-
CafePress to Present at Upcoming Investor Conference
-
Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Buy
-
Nielsen to Attend Upcoming Conferences in February
-
Agile Therapeutics, Inc. Announces Full Exercise of Option to Purchase Additional Shares by Underwriters
-
Janney Adds Three Fixed Income Professionals
-
Cantor Fitzgerald Downgrades Heat Biologics (HTBX) to Spec. Buy
-
Rambler Metals & Mining PLC: Issuance of Share
-
The Life Sciences Report's 2016 Small-Cap Biotech Watchlist
-
Brazil Resources Inc. Issues Letter to Shareholders and Reports on Company Outlook for 2016
-
Ur-Energy Announces Bought Deal Financing
-
Twitter (TWTR) Shares Move to Session Highs
-
Pre-Open Stock Movers 1/26: (S) (FMER) (FCX) Higher; (ENOC) (PII) (SSYS) Lower (more...)
-
Twitter (TWTR) Executive Exodus Puts it in Play - Cantor Fitzgerald
-
Cantor Fitzgerald Upgrades Bruker (BRKR) to Buy
-
Agile Therapeutics (AGRX) Prices 5.5M Common Stock Offering at $6.35/Share
-
Agile Therapeutics Announces Pricing of Its Public Offering of Common Stock
-
Agile Therapeutics (AGRX) Plans $30M Common Stock Offering


